Global Ankylosing Spondylitis Drugs Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
Ankylosing Spondylitis Drugs are drugs for Ankylosing spondylitis. Ankylosing spondylitis (AS) is a type of arthritis in which there is long term inflammation of the joints of the spine. Typically the joints where the spine joins the pelvis are also affected. Occasionally other joints such as the shoulders or hips are involved. Eye and bowel problems may also occur. Back pain is a characteristic symptom of AS, and it often comes and goes. Stiffness of the affected joints generally worsens over time.
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Ankylosing Spondylitis Drugs market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Ankylosing Spondylitis Drugs market are covered in Chapter 9:
Boehringer Ingelheim
Regeneron Pharmaceuticals
Merck?Co. Inc.
Reliance Life Sciences Pvt. Ltd.
UCB
Momenta Pharmaceuticals Inc.
Johnson & Johnson
Janssen Biotech, Inc.
Pfizer Inc.
Merck & Co.
Celgene Corporation
Amgen
Sandoz International GmbH
Abbvie
Protalix BioTherapeutics?Inc.
In Chapter 5 and Chapter 7.3, based on types, the Ankylosing Spondylitis Drugs market from 2017 to 2027 is primarily split into:
Biologics
Small Molecules
In Chapter 6 and Chapter 7.4, based on applications, the Ankylosing Spondylitis Drugs market from 2017 to 2027 covers:
Oral
Parenteral
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Ankylosing Spondylitis Drugs market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Ankylosing Spondylitis Drugs Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 ANKYLOSING SPONDYLITIS DRUGS MARKET OVERVIEW
1.1 Product Overview and Scope of Ankylosing Spondylitis Drugs Market
1.2 Ankylosing Spondylitis Drugs Market Segment by Type
1.2.1 Global Ankylosing Spondylitis Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Ankylosing Spondylitis Drugs Market Segment by Application
1.3.1 Ankylosing Spondylitis Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Ankylosing Spondylitis Drugs Market, Region Wise (2017-2027)
1.4.1 Global Ankylosing Spondylitis Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Ankylosing Spondylitis Drugs Market Status and Prospect (2017-2027)
1.4.3 Europe Ankylosing Spondylitis Drugs Market Status and Prospect (2017-2027)
1.4.4 China Ankylosing Spondylitis Drugs Market Status and Prospect (2017-2027)
1.4.5 Japan Ankylosing Spondylitis Drugs Market Status and Prospect (2017-2027)
1.4.6 India Ankylosing Spondylitis Drugs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Ankylosing Spondylitis Drugs Market Status and Prospect (2017-2027)
1.4.8 Latin America Ankylosing Spondylitis Drugs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Ankylosing Spondylitis Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Ankylosing Spondylitis Drugs (2017-2027)
1.5.1 Global Ankylosing Spondylitis Drugs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Ankylosing Spondylitis Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Ankylosing Spondylitis Drugs Market
2 INDUSTRY OUTLOOK
2.1 Ankylosing Spondylitis Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Ankylosing Spondylitis Drugs Market Drivers Analysis
2.4 Ankylosing Spondylitis Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Ankylosing Spondylitis Drugs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Ankylosing Spondylitis Drugs Industry Development
3 GLOBAL ANKYLOSING SPONDYLITIS DRUGS MARKET LANDSCAPE BY PLAYER
3.1 Global Ankylosing Spondylitis Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Ankylosing Spondylitis Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Ankylosing Spondylitis Drugs Average Price by Player (2017-2022)
3.4 Global Ankylosing Spondylitis Drugs Gross Margin by Player (2017-2022)
3.5 Ankylosing Spondylitis Drugs Market Competitive Situation and Trends
3.5.1 Ankylosing Spondylitis Drugs Market Concentration Rate
3.5.2 Ankylosing Spondylitis Drugs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ANKYLOSING SPONDYLITIS DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Ankylosing Spondylitis Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Ankylosing Spondylitis Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Ankylosing Spondylitis Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Ankylosing Spondylitis Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Ankylosing Spondylitis Drugs Market Under COVID-19
4.5 Europe Ankylosing Spondylitis Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Ankylosing Spondylitis Drugs Market Under COVID-19
4.6 China Ankylosing Spondylitis Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Ankylosing Spondylitis Drugs Market Under COVID-19
4.7 Japan Ankylosing Spondylitis Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Ankylosing Spondylitis Drugs Market Under COVID-19
4.8 India Ankylosing Spondylitis Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Ankylosing Spondylitis Drugs Market Under COVID-19
4.9 Southeast Asia Ankylosing Spondylitis Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Ankylosing Spondylitis Drugs Market Under COVID-19
4.10 Latin America Ankylosing Spondylitis Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Ankylosing Spondylitis Drugs Market Under COVID-19
4.11 Middle East and Africa Ankylosing Spondylitis Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Ankylosing Spondylitis Drugs Market Under COVID-19
5 GLOBAL ANKYLOSING SPONDYLITIS DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Ankylosing Spondylitis Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Ankylosing Spondylitis Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Ankylosing Spondylitis Drugs Price by Type (2017-2022)
5.4 Global Ankylosing Spondylitis Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Ankylosing Spondylitis Drugs Sales Volume, Revenue and Growth Rate of Biologics (2017-2022)
5.4.2 Global Ankylosing Spondylitis Drugs Sales Volume, Revenue and Growth Rate of Small Molecules (2017-2022)
6 GLOBAL ANKYLOSING SPONDYLITIS DRUGS MARKET ANALYSIS BY APPLICATION
6.1 Global Ankylosing Spondylitis Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Ankylosing Spondylitis Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Ankylosing Spondylitis Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Ankylosing Spondylitis Drugs Consumption and Growth Rate of Oral (2017-2022)
6.3.2 Global Ankylosing Spondylitis Drugs Consumption and Growth Rate of Parenteral (2017-2022)
7 GLOBAL ANKYLOSING SPONDYLITIS DRUGS MARKET FORECAST (2022-2027)
7.1 Global Ankylosing Spondylitis Drugs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Ankylosing Spondylitis Drugs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Ankylosing Spondylitis Drugs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Ankylosing Spondylitis Drugs Price and Trend Forecast (2022-2027)
7.2 Global Ankylosing Spondylitis Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Ankylosing Spondylitis Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Ankylosing Spondylitis Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Ankylosing Spondylitis Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Ankylosing Spondylitis Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Ankylosing Spondylitis Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Ankylosing Spondylitis Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Ankylosing Spondylitis Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Ankylosing Spondylitis Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Ankylosing Spondylitis Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Ankylosing Spondylitis Drugs Revenue and Growth Rate of Biologics (2022-2027)
7.3.2 Global Ankylosing Spondylitis Drugs Revenue and Growth Rate of Small Molecules (2022-2027)
7.4 Global Ankylosing Spondylitis Drugs Consumption Forecast by Application (2022-2027)
7.4.1 Global Ankylosing Spondylitis Drugs Consumption Value and Growth Rate of Oral(2022-2027)
7.4.2 Global Ankylosing Spondylitis Drugs Consumption Value and Growth Rate of Parenteral(2022-2027)
7.5 Ankylosing Spondylitis Drugs Market Forecast Under COVID-19
8 ANKYLOSING SPONDYLITIS DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Ankylosing Spondylitis Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Ankylosing Spondylitis Drugs Analysis
8.6 Major Downstream Buyers of Ankylosing Spondylitis Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Ankylosing Spondylitis Drugs Industry
9 PLAYERS PROFILES
9.1 Boehringer Ingelheim
9.1.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.1.3 Boehringer Ingelheim Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Regeneron Pharmaceuticals
9.2.1 Regeneron Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.2.3 Regeneron Pharmaceuticals Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Merck?Co. Inc.
9.3.1 Merck?Co. Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.3.3 Merck?Co. Inc. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Reliance Life Sciences Pvt. Ltd.
9.4.1 Reliance Life Sciences Pvt. Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.4.3 Reliance Life Sciences Pvt. Ltd. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 UCB
9.5.1 UCB Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.5.3 UCB Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Momenta Pharmaceuticals Inc.
9.6.1 Momenta Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.6.3 Momenta Pharmaceuticals Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Johnson & Johnson
9.7.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.7.3 Johnson & Johnson Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Janssen Biotech, Inc.
9.8.1 Janssen Biotech, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.8.3 Janssen Biotech, Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Pfizer Inc.
9.9.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.9.3 Pfizer Inc. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Merck & Co.
9.10.1 Merck & Co. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.10.3 Merck & Co. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Celgene Corporation
9.11.1 Celgene Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.11.3 Celgene Corporation Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Amgen
9.12.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.12.3 Amgen Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Sandoz International GmbH
9.13.1 Sandoz International GmbH Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.13.3 Sandoz International GmbH Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Abbvie
9.14.1 Abbvie Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.14.3 Abbvie Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Protalix BioTherapeutics?Inc.
9.15.1 Protalix BioTherapeutics?Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.15.3 Protalix BioTherapeutics?Inc. Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Ankylosing Spondylitis Drugs Market
1.2 Ankylosing Spondylitis Drugs Market Segment by Type
1.2.1 Global Ankylosing Spondylitis Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Ankylosing Spondylitis Drugs Market Segment by Application
1.3.1 Ankylosing Spondylitis Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Ankylosing Spondylitis Drugs Market, Region Wise (2017-2027)
1.4.1 Global Ankylosing Spondylitis Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Ankylosing Spondylitis Drugs Market Status and Prospect (2017-2027)
1.4.3 Europe Ankylosing Spondylitis Drugs Market Status and Prospect (2017-2027)
1.4.4 China Ankylosing Spondylitis Drugs Market Status and Prospect (2017-2027)
1.4.5 Japan Ankylosing Spondylitis Drugs Market Status and Prospect (2017-2027)
1.4.6 India Ankylosing Spondylitis Drugs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Ankylosing Spondylitis Drugs Market Status and Prospect (2017-2027)
1.4.8 Latin America Ankylosing Spondylitis Drugs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Ankylosing Spondylitis Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Ankylosing Spondylitis Drugs (2017-2027)
1.5.1 Global Ankylosing Spondylitis Drugs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Ankylosing Spondylitis Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Ankylosing Spondylitis Drugs Market
2 INDUSTRY OUTLOOK
2.1 Ankylosing Spondylitis Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Ankylosing Spondylitis Drugs Market Drivers Analysis
2.4 Ankylosing Spondylitis Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Ankylosing Spondylitis Drugs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Ankylosing Spondylitis Drugs Industry Development
3 GLOBAL ANKYLOSING SPONDYLITIS DRUGS MARKET LANDSCAPE BY PLAYER
3.1 Global Ankylosing Spondylitis Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Ankylosing Spondylitis Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Ankylosing Spondylitis Drugs Average Price by Player (2017-2022)
3.4 Global Ankylosing Spondylitis Drugs Gross Margin by Player (2017-2022)
3.5 Ankylosing Spondylitis Drugs Market Competitive Situation and Trends
3.5.1 Ankylosing Spondylitis Drugs Market Concentration Rate
3.5.2 Ankylosing Spondylitis Drugs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ANKYLOSING SPONDYLITIS DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Ankylosing Spondylitis Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Ankylosing Spondylitis Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Ankylosing Spondylitis Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Ankylosing Spondylitis Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Ankylosing Spondylitis Drugs Market Under COVID-19
4.5 Europe Ankylosing Spondylitis Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Ankylosing Spondylitis Drugs Market Under COVID-19
4.6 China Ankylosing Spondylitis Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Ankylosing Spondylitis Drugs Market Under COVID-19
4.7 Japan Ankylosing Spondylitis Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Ankylosing Spondylitis Drugs Market Under COVID-19
4.8 India Ankylosing Spondylitis Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Ankylosing Spondylitis Drugs Market Under COVID-19
4.9 Southeast Asia Ankylosing Spondylitis Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Ankylosing Spondylitis Drugs Market Under COVID-19
4.10 Latin America Ankylosing Spondylitis Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Ankylosing Spondylitis Drugs Market Under COVID-19
4.11 Middle East and Africa Ankylosing Spondylitis Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Ankylosing Spondylitis Drugs Market Under COVID-19
5 GLOBAL ANKYLOSING SPONDYLITIS DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Ankylosing Spondylitis Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Ankylosing Spondylitis Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Ankylosing Spondylitis Drugs Price by Type (2017-2022)
5.4 Global Ankylosing Spondylitis Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Ankylosing Spondylitis Drugs Sales Volume, Revenue and Growth Rate of Biologics (2017-2022)
5.4.2 Global Ankylosing Spondylitis Drugs Sales Volume, Revenue and Growth Rate of Small Molecules (2017-2022)
6 GLOBAL ANKYLOSING SPONDYLITIS DRUGS MARKET ANALYSIS BY APPLICATION
6.1 Global Ankylosing Spondylitis Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Ankylosing Spondylitis Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Ankylosing Spondylitis Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Ankylosing Spondylitis Drugs Consumption and Growth Rate of Oral (2017-2022)
6.3.2 Global Ankylosing Spondylitis Drugs Consumption and Growth Rate of Parenteral (2017-2022)
7 GLOBAL ANKYLOSING SPONDYLITIS DRUGS MARKET FORECAST (2022-2027)
7.1 Global Ankylosing Spondylitis Drugs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Ankylosing Spondylitis Drugs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Ankylosing Spondylitis Drugs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Ankylosing Spondylitis Drugs Price and Trend Forecast (2022-2027)
7.2 Global Ankylosing Spondylitis Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Ankylosing Spondylitis Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Ankylosing Spondylitis Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Ankylosing Spondylitis Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Ankylosing Spondylitis Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Ankylosing Spondylitis Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Ankylosing Spondylitis Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Ankylosing Spondylitis Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Ankylosing Spondylitis Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Ankylosing Spondylitis Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Ankylosing Spondylitis Drugs Revenue and Growth Rate of Biologics (2022-2027)
7.3.2 Global Ankylosing Spondylitis Drugs Revenue and Growth Rate of Small Molecules (2022-2027)
7.4 Global Ankylosing Spondylitis Drugs Consumption Forecast by Application (2022-2027)
7.4.1 Global Ankylosing Spondylitis Drugs Consumption Value and Growth Rate of Oral(2022-2027)
7.4.2 Global Ankylosing Spondylitis Drugs Consumption Value and Growth Rate of Parenteral(2022-2027)
7.5 Ankylosing Spondylitis Drugs Market Forecast Under COVID-19
8 ANKYLOSING SPONDYLITIS DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Ankylosing Spondylitis Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Ankylosing Spondylitis Drugs Analysis
8.6 Major Downstream Buyers of Ankylosing Spondylitis Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Ankylosing Spondylitis Drugs Industry
9 PLAYERS PROFILES
9.1 Boehringer Ingelheim
9.1.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.1.3 Boehringer Ingelheim Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Regeneron Pharmaceuticals
9.2.1 Regeneron Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.2.3 Regeneron Pharmaceuticals Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Merck?Co. Inc.
9.3.1 Merck?Co. Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.3.3 Merck?Co. Inc. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Reliance Life Sciences Pvt. Ltd.
9.4.1 Reliance Life Sciences Pvt. Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.4.3 Reliance Life Sciences Pvt. Ltd. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 UCB
9.5.1 UCB Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.5.3 UCB Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Momenta Pharmaceuticals Inc.
9.6.1 Momenta Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.6.3 Momenta Pharmaceuticals Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Johnson & Johnson
9.7.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.7.3 Johnson & Johnson Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Janssen Biotech, Inc.
9.8.1 Janssen Biotech, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.8.3 Janssen Biotech, Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Pfizer Inc.
9.9.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.9.3 Pfizer Inc. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Merck & Co.
9.10.1 Merck & Co. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.10.3 Merck & Co. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Celgene Corporation
9.11.1 Celgene Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.11.3 Celgene Corporation Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Amgen
9.12.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.12.3 Amgen Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Sandoz International GmbH
9.13.1 Sandoz International GmbH Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.13.3 Sandoz International GmbH Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Abbvie
9.14.1 Abbvie Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.14.3 Abbvie Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Protalix BioTherapeutics?Inc.
9.15.1 Protalix BioTherapeutics?Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Ankylosing Spondylitis Drugs Product Profiles, Application and Specification
9.15.3 Protalix BioTherapeutics?Inc. Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Ankylosing Spondylitis Drugs Product Picture
Table Global Ankylosing Spondylitis Drugs Market Sales Volume and CAGR (%) Comparison by Type
Table Ankylosing Spondylitis Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Ankylosing Spondylitis Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Ankylosing Spondylitis Drugs Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Ankylosing Spondylitis Drugs Industry Development
Table Global Ankylosing Spondylitis Drugs Sales Volume by Player (2017-2022)
Table Global Ankylosing Spondylitis Drugs Sales Volume Share by Player (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Sales Volume Share by Player in 2021
Table Ankylosing Spondylitis Drugs Revenue (Million USD) by Player (2017-2022)
Table Ankylosing Spondylitis Drugs Revenue Market Share by Player (2017-2022)
Table Ankylosing Spondylitis Drugs Price by Player (2017-2022)
Table Ankylosing Spondylitis Drugs Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Ankylosing Spondylitis Drugs Sales Volume, Region Wise (2017-2022)
Table Global Ankylosing Spondylitis Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Sales Volume Market Share, Region Wise in 2021
Table Global Ankylosing Spondylitis Drugs Revenue (Million USD), Region Wise (2017-2022)
Table Global Ankylosing Spondylitis Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Revenue Market Share, Region Wise in 2021
Table Global Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Ankylosing Spondylitis Drugs Sales Volume by Type (2017-2022)
Table Global Ankylosing Spondylitis Drugs Sales Volume Market Share by Type (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Sales Volume Market Share by Type in 2021
Table Global Ankylosing Spondylitis Drugs Revenue (Million USD) by Type (2017-2022)
Table Global Ankylosing Spondylitis Drugs Revenue Market Share by Type (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Revenue Market Share by Type in 2021
Table Ankylosing Spondylitis Drugs Price by Type (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Sales Volume and Growth Rate of Biologics (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Revenue (Million USD) and Growth Rate of Biologics (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Sales Volume and Growth Rate of Small Molecules (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Revenue (Million USD) and Growth Rate of Small Molecules (2017-2022)
Table Global Ankylosing Spondylitis Drugs Consumption by Application (2017-2022)
Table Global Ankylosing Spondylitis Drugs Consumption Market Share by Application (2017-2022)
Table Global Ankylosing Spondylitis Drugs Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Ankylosing Spondylitis Drugs Consumption Revenue Market Share by Application (2017-2022)
Table Global Ankylosing Spondylitis Drugs Consumption and Growth Rate of Oral (2017-2022)
Table Global Ankylosing Spondylitis Drugs Consumption and Growth Rate of Parenteral (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Ankylosing Spondylitis Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Ankylosing Spondylitis Drugs Price and Trend Forecast (2022-2027)
Figure USA Ankylosing Spondylitis Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Ankylosing Spondylitis Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Ankylosing Spondylitis Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Ankylosing Spondylitis Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Ankylosing Spondylitis Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Ankylosing Spondylitis Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Ankylosing Spondylitis Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Ankylosing Spondylitis Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Ankylosing Spondylitis Drugs Market Sales Volume Forecast, by Type
Table Global Ankylosing Spondylitis Drugs Sales Volume Market Share Forecast, by Type
Table Global Ankylosing Spondylitis Drugs Market Revenue (Million USD) Forecast, by Type
Table Global Ankylosing Spondylitis Drugs Revenue Market Share Forecast, by Type
Table Global Ankylosing Spondylitis Drugs Price Forecast, by Type
Figure Global Ankylosing Spondylitis Drugs Revenue (Million USD) and Growth Rate of Biologics (2022-2027)
Figure Global Ankylosing Spondylitis Drugs Revenue (Million USD) and Growth Rate of Biologics (2022-2027)
Figure Global Ankylosing Spondylitis Drugs Revenue (Million USD) and Growth Rate of Small Molecules (2022-2027)
Figure Global Ankylosing Spondylitis Drugs Revenue (Million USD) and Growth Rate of Small Molecules (2022-2027)
Table Global Ankylosing Spondylitis Drugs Market Consumption Forecast, by Application
Table Global Ankylosing Spondylitis Drugs Consumption Market Share Forecast, by Application
Table Global Ankylosing Spondylitis Drugs Market Revenue (Million USD) Forecast, by Application
Table Global Ankylosing Spondylitis Drugs Revenue Market Share Forecast, by Application
Figure Global Ankylosing Spondylitis Drugs Consumption Value (Million USD) and Growth Rate of Oral (2022-2027)
Figure Global Ankylosing Spondylitis Drugs Consumption Value (Million USD) and Growth Rate of Parenteral (2022-2027)
Figure Ankylosing Spondylitis Drugs Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Boehringer Ingelheim Revenue (Million USD) Market Share 2017-2022
Table Regeneron Pharmaceuticals Profile
Table Regeneron Pharmaceuticals Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Regeneron Pharmaceuticals Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Regeneron Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Merck?Co. Inc. Profile
Table Merck?Co. Inc. Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck?Co. Inc. Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Merck?Co. Inc. Revenue (Million USD) Market Share 2017-2022
Table Reliance Life Sciences Pvt. Ltd. Profile
Table Reliance Life Sciences Pvt. Ltd. Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Reliance Life Sciences Pvt. Ltd. Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Reliance Life Sciences Pvt. Ltd. Revenue (Million USD) Market Share 2017-2022
Table UCB Profile
Table UCB Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure UCB Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure UCB Revenue (Million USD) Market Share 2017-2022
Table Momenta Pharmaceuticals Inc. Profile
Table Momenta Pharmaceuticals Inc. Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Momenta Pharmaceuticals Inc. Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Momenta Pharmaceuticals Inc. Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
Table Janssen Biotech, Inc. Profile
Table Janssen Biotech, Inc. Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Janssen Biotech, Inc. Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Janssen Biotech, Inc. Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
Table Merck & Co. Profile
Table Merck & Co. Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co. Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Merck & Co. Revenue (Million USD) Market Share 2017-2022
Table Celgene Corporation Profile
Table Celgene Corporation Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celgene Corporation Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Celgene Corporation Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022
Table Sandoz International GmbH Profile
Table Sandoz International GmbH Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sandoz International GmbH Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Sandoz International GmbH Revenue (Million USD) Market Share 2017-2022
Table Abbvie Profile
Table Abbvie Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbvie Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Abbvie Revenue (Million USD) Market Share 2017-2022
Table Protalix BioTherapeutics?Inc. Profile
Table Protalix BioTherapeutics?Inc. Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Protalix BioTherapeutics?Inc. Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Protalix BioTherapeutics?Inc. Revenue (Million USD) Market Share 2017-2022
Figure Ankylosing Spondylitis Drugs Product Picture
Table Global Ankylosing Spondylitis Drugs Market Sales Volume and CAGR (%) Comparison by Type
Table Ankylosing Spondylitis Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Ankylosing Spondylitis Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Ankylosing Spondylitis Drugs Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Ankylosing Spondylitis Drugs Industry Development
Table Global Ankylosing Spondylitis Drugs Sales Volume by Player (2017-2022)
Table Global Ankylosing Spondylitis Drugs Sales Volume Share by Player (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Sales Volume Share by Player in 2021
Table Ankylosing Spondylitis Drugs Revenue (Million USD) by Player (2017-2022)
Table Ankylosing Spondylitis Drugs Revenue Market Share by Player (2017-2022)
Table Ankylosing Spondylitis Drugs Price by Player (2017-2022)
Table Ankylosing Spondylitis Drugs Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Ankylosing Spondylitis Drugs Sales Volume, Region Wise (2017-2022)
Table Global Ankylosing Spondylitis Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Sales Volume Market Share, Region Wise in 2021
Table Global Ankylosing Spondylitis Drugs Revenue (Million USD), Region Wise (2017-2022)
Table Global Ankylosing Spondylitis Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Revenue Market Share, Region Wise in 2021
Table Global Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Ankylosing Spondylitis Drugs Sales Volume by Type (2017-2022)
Table Global Ankylosing Spondylitis Drugs Sales Volume Market Share by Type (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Sales Volume Market Share by Type in 2021
Table Global Ankylosing Spondylitis Drugs Revenue (Million USD) by Type (2017-2022)
Table Global Ankylosing Spondylitis Drugs Revenue Market Share by Type (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Revenue Market Share by Type in 2021
Table Ankylosing Spondylitis Drugs Price by Type (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Sales Volume and Growth Rate of Biologics (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Revenue (Million USD) and Growth Rate of Biologics (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Sales Volume and Growth Rate of Small Molecules (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Revenue (Million USD) and Growth Rate of Small Molecules (2017-2022)
Table Global Ankylosing Spondylitis Drugs Consumption by Application (2017-2022)
Table Global Ankylosing Spondylitis Drugs Consumption Market Share by Application (2017-2022)
Table Global Ankylosing Spondylitis Drugs Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Ankylosing Spondylitis Drugs Consumption Revenue Market Share by Application (2017-2022)
Table Global Ankylosing Spondylitis Drugs Consumption and Growth Rate of Oral (2017-2022)
Table Global Ankylosing Spondylitis Drugs Consumption and Growth Rate of Parenteral (2017-2022)
Figure Global Ankylosing Spondylitis Drugs Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Ankylosing Spondylitis Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Ankylosing Spondylitis Drugs Price and Trend Forecast (2022-2027)
Figure USA Ankylosing Spondylitis Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Ankylosing Spondylitis Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Ankylosing Spondylitis Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Ankylosing Spondylitis Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Ankylosing Spondylitis Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Ankylosing Spondylitis Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Ankylosing Spondylitis Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Ankylosing Spondylitis Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Ankylosing Spondylitis Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Ankylosing Spondylitis Drugs Market Sales Volume Forecast, by Type
Table Global Ankylosing Spondylitis Drugs Sales Volume Market Share Forecast, by Type
Table Global Ankylosing Spondylitis Drugs Market Revenue (Million USD) Forecast, by Type
Table Global Ankylosing Spondylitis Drugs Revenue Market Share Forecast, by Type
Table Global Ankylosing Spondylitis Drugs Price Forecast, by Type
Figure Global Ankylosing Spondylitis Drugs Revenue (Million USD) and Growth Rate of Biologics (2022-2027)
Figure Global Ankylosing Spondylitis Drugs Revenue (Million USD) and Growth Rate of Biologics (2022-2027)
Figure Global Ankylosing Spondylitis Drugs Revenue (Million USD) and Growth Rate of Small Molecules (2022-2027)
Figure Global Ankylosing Spondylitis Drugs Revenue (Million USD) and Growth Rate of Small Molecules (2022-2027)
Table Global Ankylosing Spondylitis Drugs Market Consumption Forecast, by Application
Table Global Ankylosing Spondylitis Drugs Consumption Market Share Forecast, by Application
Table Global Ankylosing Spondylitis Drugs Market Revenue (Million USD) Forecast, by Application
Table Global Ankylosing Spondylitis Drugs Revenue Market Share Forecast, by Application
Figure Global Ankylosing Spondylitis Drugs Consumption Value (Million USD) and Growth Rate of Oral (2022-2027)
Figure Global Ankylosing Spondylitis Drugs Consumption Value (Million USD) and Growth Rate of Parenteral (2022-2027)
Figure Ankylosing Spondylitis Drugs Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Boehringer Ingelheim Revenue (Million USD) Market Share 2017-2022
Table Regeneron Pharmaceuticals Profile
Table Regeneron Pharmaceuticals Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Regeneron Pharmaceuticals Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Regeneron Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Merck?Co. Inc. Profile
Table Merck?Co. Inc. Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck?Co. Inc. Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Merck?Co. Inc. Revenue (Million USD) Market Share 2017-2022
Table Reliance Life Sciences Pvt. Ltd. Profile
Table Reliance Life Sciences Pvt. Ltd. Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Reliance Life Sciences Pvt. Ltd. Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Reliance Life Sciences Pvt. Ltd. Revenue (Million USD) Market Share 2017-2022
Table UCB Profile
Table UCB Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure UCB Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure UCB Revenue (Million USD) Market Share 2017-2022
Table Momenta Pharmaceuticals Inc. Profile
Table Momenta Pharmaceuticals Inc. Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Momenta Pharmaceuticals Inc. Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Momenta Pharmaceuticals Inc. Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
Table Janssen Biotech, Inc. Profile
Table Janssen Biotech, Inc. Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Janssen Biotech, Inc. Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Janssen Biotech, Inc. Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
Table Merck & Co. Profile
Table Merck & Co. Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co. Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Merck & Co. Revenue (Million USD) Market Share 2017-2022
Table Celgene Corporation Profile
Table Celgene Corporation Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celgene Corporation Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Celgene Corporation Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022
Table Sandoz International GmbH Profile
Table Sandoz International GmbH Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sandoz International GmbH Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Sandoz International GmbH Revenue (Million USD) Market Share 2017-2022
Table Abbvie Profile
Table Abbvie Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbvie Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Abbvie Revenue (Million USD) Market Share 2017-2022
Table Protalix BioTherapeutics?Inc. Profile
Table Protalix BioTherapeutics?Inc. Ankylosing Spondylitis Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Protalix BioTherapeutics?Inc. Ankylosing Spondylitis Drugs Sales Volume and Growth Rate
Figure Protalix BioTherapeutics?Inc. Revenue (Million USD) Market Share 2017-2022
